Precision medicine has been well recognized since it was proposed, and the invention of liquid biopsy meets the needs of this era. Circulating tumor DNA (ctDNA), one of the most promising components of liquid biopsies, has quickly become the focus of research in recent years because of its unique advantages in clinical application. This article reviews the clinical application of ctDNA in breast cancer detection in recent years and its potential clinical value.
基金：
National Natural Science Foundation of China [81760262]
第一作者机构：[1]Kunming Univ Sci & Technol, Fac Life Sci & Biotechnol, Kunming, Yunnan, Peoples R China
通讯作者：
通讯机构：[2]Kunming Univ Sci & Technol, Med Fac, Lab Mol Genet Aging & Tumor, Kunming 650500, Yunnan, Peoples R China[4]First Peoples Hosp Yunnan Prov, Dept Breast & Thyroid Surg, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China[*1]Laboratory of Molecular Genetics of Aging & Tumor, Medical Faculty, Kunming University of Science and Technology, Kunming, Yunnan 650500, China[*2]Department of Breast and thyroid surgery, First People’s Hospital of Yunnan Province, 157 Jinbi Road, Kunming, Yunnan 650032, China.
推荐引用方式(GB/T 7714)：
Zhao Yuan,Sheng Miaomiao,Zheng Ling,et al.Application of circulating tumor DNA in breast cancer[J].BREAST JOURNAL.2020,26(9):1797-1800.doi:10.1111/tbj.13775.
APA：
Zhao, Yuan,Sheng, Miaomiao,Zheng, Ling,Xiong, Dun,Yang, Kunxian&Luo, Ying.(2020).Application of circulating tumor DNA in breast cancer.BREAST JOURNAL,26,(9)
MLA：
Zhao, Yuan,et al."Application of circulating tumor DNA in breast cancer".BREAST JOURNAL 26..9(2020):1797-1800
